The Ahmedabad based Zydus Cadilla's vaccine (ZyCoV-D) is the second indigenous vaccine against Covid-19 Wuhan virus. The company will be seeing emergency authorization in India soon. The Phase 3 study had more than 28,000 volunteers.
ZyCoV-D will be the world's first DNA Plasmid-based vaccine. Another feature of this vaccine is that it is administered without using a needle but via skin. It requires 3 doses for complete effectiveness.
More here:
COVID-19 Vaccine: Zydus Cadila to seek emergency authorization for ZyCoV-D vaccine next week (jagranjosh.com)
India is presently administering Covaxin, Covishied and Sputnik V. Pfizer and Moderna are also likely to enter the picture soon.
No comments:
Post a Comment